A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants

NCT05970718 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: REGN7544
DRUG: Matching Placebo

Sponsor

Regeneron Pharmaceuticals